Related Experiment Videos
Preliminary report on the effects of diet discontinuation in PKU
Insights
Discontinuing the phenylalanine-restricted diet in children with phenylketonuria (PKU) may lead to subtle changes in brain function. Further research is needed to understand the long-term effects of diet discontinuation in PKU patients.
Area of Science:
- Neuroscience
- Pediatric Medicine
- Metabolic Disorders
Background:
- Phenylketonuria (PKU) is a rare genetic disorder requiring lifelong dietary management.
- Early intervention with a phenylalanine-restricted diet is crucial for neurodevelopment in children with PKU.
Purpose of the Study:
- To investigate the effects of discontinuing the phenylalanine-restricted diet on cognitive and academic outcomes in children with PKU.
- To assess potential subtle changes in cerebral function following diet cessation.
Main Methods:
- A longitudinal study involving 115 children with PKU, randomly assigned at age 6 to continue or discontinue their diet.
- Cognitive assessments included IQ testing (Stanford-Binet and WISC) and academic achievement (Wide Range Achievement Test).
Main Results:
- While IQ scores showed minimal differences between groups at age 8, reading and spelling grade placements were significantly lower in children who discontinued the diet.
- Arithmetic scores did not differ significantly between the groups.
- Preliminary data suggest potential subtle alterations in cerebral function in children with PKU after diet discontinuation.
Conclusions:
- Discontinuing the phenylalanine-restricted diet in children with PKU may be associated with subtle neurocognitive effects, particularly in language-based academic skills.
- These findings highlight the importance of ongoing dietary management and monitoring in PKU.
- Further research is warranted to elucidate the long-term neurological consequences of diet discontinuation in PKU.
Abstract:
A collaborative study of diet discontinuation in children with PKU was initiated in 1973. Children treated with the phenylalanine-restricted diet since early infancy were randomly assigned to continue or discontinue dietary therapy at age 6 years after parental consent was obtained. The 115 children participating in this study range in age from 8 to 13 years. At 6 years of age, the IQ of continuers and discontinuers was 101 and 97, respectively. At 8 years, WISC Full-Scale IQ scores adjusted for mean differences on the 6-year Stanford-Binet IQ were 101 for continuers and 98 for discontinuers (P = 0.075). School performance measured by the Wide Range Achievement Test showed significant differences on reading (3.9 vs 3.2) and spelling (3.3 vs 2.9) grade placement, although scores were above actual grade placement (2.7 vs 2.6) for both groups. Continuers and discontinuers were not different in arithmetic scores, with performance at grade placement of 2.7 and 2.6 respectively. Although these data are preliminary in nature, they suggest that subtle changes in cerebral function may occur in children with PKU in whom the phenylalanine diet has been discontinued.